• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A1亚基介导的凝血酶激活的因子VIII A2亚基解离的调节。

A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation.

作者信息

Parker Ernest T, Doering Christopher B, Lollar Pete

机构信息

Aflac Cancer Center and Blood Disorders Service, Children's Healthcare of Atlanta, Georgia 30322, USA.

出版信息

J Biol Chem. 2006 May 19;281(20):13922-30. doi: 10.1074/jbc.M513124200. Epub 2006 Mar 2.

DOI:10.1074/jbc.M513124200
PMID:16513639
Abstract

Factor VIII (fVIII) is the plasma protein that is missing or deficient in hemophilia A. In contrast, elevated levels of fVIII are associated with an increased risk of arterial and venous thrombosis. fVIII is activated by thrombin to form a non-covalently linked A1/A2/A3-C1-C2 heterotrimer. At physiological concentrations, fVIIIa decays as a result of A2 subunit dissociation, which may help regulate the balance between hemostasis and thrombosis. A2 subunit dissociation is faster in human fVIIIa than in porcine fVIIIa, which may represent an evolutionary adaptation associated with the development of the upright posture and venous stasis in the lower extremities. To investigate the basis for the different decay kinetics of human and porcine fVIIIa, hybrid fVIII molecules representing all possible combinations of human and porcine A domains were isolated. The kinetics of fVIIIa decay were measured and fit to a model describing a reversible bimolecular reaction in which the dissociation rate constant, k, and dissociation constant, Kd, were the fitted parameters. Substitution of the porcine A1 domain into human fVIIIa produced a dissociation rate constant indistinguishable from porcine fVIIIa. Subsequently, substitution of the second cupredoxin-like A1 subdomain resulted in a dissociation rate constant similar to porcine fVIIIa, whereas substitution of the first cupredoxin-like A1 subdomain resulted in a dissociation rate constant intermediate between human and porcine fVIIIa. We propose that cupredoxin-like A1 subdomains in fVIII contain inter-species differences that are a result of selective pressure on the dissociation rate constant.

摘要

凝血因子VIII(fVIII)是甲型血友病患者体内缺失或缺乏的血浆蛋白。相反,fVIII水平升高与动脉和静脉血栓形成风险增加有关。fVIII被凝血酶激活后形成非共价连接的A1/A2/A3-C1-C2异源三聚体。在生理浓度下,fVIIIa会因A2亚基解离而衰变,这可能有助于调节止血和血栓形成之间的平衡。人fVIIIa的A2亚基解离速度比猪fVIIIa快,这可能代表了一种与直立姿势发展和下肢静脉淤滞相关的进化适应。为了研究人源和猪源fVIIIa衰变动力学差异的基础,分离出了代表人和猪A结构域所有可能组合的杂交fVIII分子。测量了fVIIIa衰变的动力学,并将其拟合到一个描述可逆双分子反应的模型中,其中解离速率常数k和解离常数Kd是拟合参数。将猪A1结构域替换为人fVIIIa后,产生的解离速率常数与猪fVIIIa无法区分。随后,替换第二个类铜蓝蛋白样A1亚结构域导致解离速率常数与猪fVIIIa相似,而替换第一个类铜蓝蛋白样A1亚结构域导致解离速率常数介于人和猪fVIIIa之间。我们提出,fVIII中类铜蓝蛋白样A1亚结构域存在种间差异,这是对解离速率常数的选择压力导致的结果。

相似文献

1
A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation.A1亚基介导的凝血酶激活的因子VIII A2亚基解离的调节。
J Biol Chem. 2006 May 19;281(20):13922-30. doi: 10.1074/jbc.M513124200. Epub 2006 Mar 2.
2
Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.凝血酶激活的因子VIII中A1亚基残基Q316对A2亚基解离的作用。
Biochemistry. 2007 Aug 28;46(34):9737-42. doi: 10.1021/bi700941w. Epub 2007 Aug 4.
3
Coagulant properties of hybrid human/porcine factor VIII molecules.人/猪杂交因子VIII分子的凝血特性
J Biol Chem. 1992 Nov 25;267(33):23652-7.
4
Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa.与一期/二期活性差异相关的甲型血友病突变破坏了凝血酶激活的因子VIIIa三联A结构域内的蛋白质-蛋白质相互作用。
Blood. 2001 Feb 1;97(3):685-91. doi: 10.1182/blood.v97.3.685.
5
Hemophilia A mutations within the factor VIII A2-A3 subunit interface destabilize factor VIIIa and cause one-stage/two-stage activity discrepancy.血友病A中凝血因子VIII A2 - A3亚基界面内的突变会使凝血因子VIIIa不稳定,并导致一期/二期活性差异。
Thromb Haemost. 2002 Nov;88(5):781-7.
6
Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo.因因子VIII A2亚基解离速率增加导致的轻度甲型血友病:体内因子VIIIa非蛋白水解失活的证据
Blood. 1999 Jan 1;93(1):176-83.
7
Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.二硫键稳定的凝血因子VIIIa变体的内在稳定性和功能特性
J Thromb Haemost. 2006 Jun;4(6):1315-22. doi: 10.1111/j.1538-7836.2006.01951.x.
8
Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis.基于扫描透射电子显微镜(STEM)图像和STEM质量分析的猪源因子VIII和因子VIIIa分子结构模型
J Clin Invest. 1990 Jun;85(6):1983-90. doi: 10.1172/JCI114662.
9
Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.凝血酶对因子VIII的激活增加了其与合成磷脂膜及活化血小板结合的亲和力。
J Biol Chem. 1998 Oct 23;273(43):27918-26. doi: 10.1074/jbc.273.43.27918.
10
Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.在凝血途径中,A2-A3界面处D666-S1787与T657-Y1792之间的稳定相互作用支持凝血因子VIIIa的稳定性。
J Thromb Haemost. 2016 May;14(5):1021-30. doi: 10.1111/jth.13292. Epub 2016 Mar 21.

引用本文的文献

1
Humanization and functional characterization of enhanced coagulation factor IX variants identified through ancestral sequence reconstruction.通过祖先序列重建鉴定的增强型凝血因子 IX 变异体的人源化和功能特征。
J Thromb Haemost. 2024 Mar;22(3):633-644. doi: 10.1016/j.jtha.2023.11.010. Epub 2023 Nov 26.
2
SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.对结合到脂质纳米盘上的内源性凝血酶原酶复合物进行小角X射线散射分析,突出了凝血因子VIIIa/IXa之间的分子间接触。
Blood Adv. 2022 Jun 14;6(11):3240-3254. doi: 10.1182/bloodadvances.2021005874.
3
Activated protein C has a regulatory role in factor VIII function.
活化蛋白 C 在因子 VIII 功能中具有调节作用。
Blood. 2021 May 6;137(18):2532-2543. doi: 10.1182/blood.2020007562.
4
Enhancing therapeutic efficacy of in vivo platelet-targeted gene therapy in hemophilia A mice.增强体内血小板靶向基因治疗血友病 A 小鼠的疗效。
Blood Adv. 2020 Nov 24;4(22):5722-5734. doi: 10.1182/bloodadvances.2020002479.
5
The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain.凝血因子VIII生物工程变体的3.2 Å结构表明C2结构域存在两种构象。
J Thromb Haemost. 2020 Jan;18(1):57-69. doi: 10.1111/jth.14621. Epub 2019 Sep 8.
6
Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction.通过祖先序列重建增强蛋白质药物的药学性质。
Nat Biotechnol. 2017 Jan;35(1):35-37. doi: 10.1038/nbt.3677. Epub 2016 Sep 26.
7
High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors.高亲和力、非抑制性致病性C1结构域抗体存在于甲型血友病和有抑制剂的患者中。
Blood. 2016 Oct 20;128(16):2055-2067. doi: 10.1182/blood-2016-02-701805. Epub 2016 Jul 5.
8
Role of hydrophobic mutations on the binding affinity and stability of blood coagulation factor VIIIa: a computational molecular dynamics and free-energy analysis.疏水性突变对凝血因子 VIIIa 结合亲和力和稳定性的作用:计算分子动力学和自由能分析。
Biochem Biophys Res Commun. 2014 Jul 18;450(1):735-40. doi: 10.1016/j.bbrc.2014.06.043. Epub 2014 Jun 18.
9
The diversity of the immune response to the A2 domain of human factor VIII.人凝血因子 VIII A2 结构域的免疫应答多样性。
Blood. 2013 Apr 4;121(14):2785-95. doi: 10.1182/blood-2012-09-456582. Epub 2013 Jan 24.
10
Development and characterization of recombinant ovine coagulation factor VIII.重组绵羊凝血因子 VIII 的开发和特性研究。
PLoS One. 2012;7(11):e49481. doi: 10.1371/journal.pone.0049481. Epub 2012 Nov 9.